Archives
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Screening & Diagnosis
This presentation will discuss the screening and diagnosis, the pathophysiology, disease progression, and the physical and emotional burden of autosomal dominant polycystic kidney disease (ADPKD). The key factors that play into ADPKD screening and diagnosis will be presented.
*Dr Workeneh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Lambert is an employee of OPDC.
Featured Speakers
Biruh T Workeneh, MD, FASN
The University of Texas MD Anderson Cancer Center*
Dr Biruh Workeneh is a provider in the MD Anderson Internal Medicine Center and an Associate Professor in the Section of Nephrology. He is board-certified in Internal Medicine and joined MD Anderson in 2015.
Hannah N. Lambert, PharmD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.
